Skip to search formSkip to main contentSkip to account menu

Mucopolysaccharidosis VI

Known as: Mucopolysaccharidosis VI [Disease/Finding], MPS VI, MAROTEAUX-LAMY SYNDROME 
A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme N-acetylgalactosamine-4-sulfatase. It is characterized by… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
The concept of screening newborns for inherited metabolic disorders was the brainchild of Robert Guthrie, an upstate New York… 
Highly Cited
1998
Highly Cited
1998
Mucopolysaccharidosis type VI (MPS VI) is a lysosomal storage disease caused by a deficiency of N-acetylgalactosamine-4-sulfatase… 
1994
1994
The glycosylation and phosphorylation of the lysosomal enzyme arylsulfatase A was analyzed by a combination of metabolic labeling… 
1993
1993
High-titre stocks of an amphotropic retrovirus, constructed so as to express a full-length cDNA encoding the human lysosomal… 
Highly Cited
1984
Highly Cited
1984
Feline and human mucopolysaccharidosis VI (MPS VI or Maroteaux–Lamy syndrome) are inherited autosomal recessive deficiencies of… 
1984
1984
Spinal cord compression with resultant myelopathy is a frequent occurrence in patients with mucopolysaccharidoses. Etiological… 
1983
1983
Metachromatic leukodystrophy is a hereditary neurodegenerative disorder in man associated with deficient arylsulfatase-A activity…